A 5-year trial evaluating intrahepatic levels of covalently closed circular DNA after 3-5 years of telbivudine therapy and its relationship with serological evolution in chronic hepatitis B patients.
Latest Information Update: 30 Jan 2017
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 30 Jan 2017 New trial record